Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Clinical trials industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Phases trends
2.1.3 Study design trends
2.1.4 Therapeutic area trends
2.1.5 Regional trends
Chapter 3 Clinical trials Industry Insights
3.1 Industry segentation
3.2 Industry landscape, 2018 – 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of chronic diseases across the globe
3.3.1.2 Growing demand for outsourcing clinical trials to CROs
3.3.1.3 Rise in government and non-government funding for clinical trials
3.3.1.4 Growing opportunities for conducting clinical trials in countries of Asia Pacific
3.3.2 Industry pitfalls & challenges
3.3.2.1 Lack of skilled workforce in clinical research
3.3.2.2 Infrastructural barriers in developing countries
3.3.2.3 Challenges faced in North America & Europe for conducting clinical trials
3.4 Growth potential analysis
3.4.1 By phases
3.4.2 By study design
3.4.3 By therapeutic area
3.5 COVID-19 impact analysis
3.6 Clinical trials volume analysis
3.6.1 Clinical trials volume analysis, by region, 2018-2022
3.6.2 Clinical trials volume analysis, by phase of development, 2018-2022
3.6.3 Clinical trials volume analysis, by indication, 2018-2022
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.7.3 Asia Pacific
3.7.3.1 Singapore
3.7.3.2 Malaysia
3.7.3.3 Indonesia
3.7.3.4 Thailand
3.7.3.5 South Korea
3.7.3.6 Philippines
3.8 Clinical trials - Asia Pacific advantage
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Strategic dashboard, 2022
4.4 Merger & Acquisition landscape
4.5 Competitive analysis of major market players
4.6 Competitive positioning matrix
4.7 Strategic outlook matrix
Chapter 5 Clinical Trials Market, By Phases
5.1 Key phases trends
5.2 Phase I
5.2.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
5.3 Phase II
5.3.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
5.4 Phase III
5.4.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
5.5 Phase IV
5.5.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
Chapter 6 Clinical Trials Market, By Study Design
6.1 Key study design trends
6.2 Interventional study
6.2.1 Market size, by region, 2017 - 2030 USD Milion)
6.3 Observational study
6.3.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
6.4 Expanded access study
6.4.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
Chapter 7 Clinical Trials Market, By Therapeutic Area
7.1 Key therapeutic area trends
7.2 Autoimmune disease
7.2.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
7.3 Oncology
7.3.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
7.4 Cardiology
7.4.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
7.5 Infectious disease
7.5.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
7.6 Dermatology
7.6.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
7.7 Ophthalmology
7.7.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
7.8 Others
7.8.1 Market estimates and forecast, 2018 - 2032 (USD Milion)
Chapter 8 Clinical trials Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Russia
8.3.7 Poland
8.3.8 Switzerland
8.3.9 Netherlands
8.3.10 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Thailand
8.4.8 Singapore
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Peru
8.5.6 Rest of Latin America
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Iraq
8.6.5 Israel
8.6.6 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Thermo Fisher Scientific (PPD, Inc)
9.2 Charles River Laboratories (MPI Research)
9.3 Clinipace Inc
9.4 ICON plc
9.5 IQVIA
9.6 Laboratory Corporation of America Holding (Covance Inc)
9.7 Medpace
9.8 Parexel International Corporation
9.9 Syneos health
9.10 The Emmes Company, LLC
9.11 WuXi AppTec
Data Tables
TABLE 1. Market revenue, by phases, 2022
TABLE 2. Market share, by study design, 2022
TABLE 3. Market revenue, by therapeutic area, 2022
TABLE 4. Market share, by region, 2022
TABLE 5. Global clinical trials market, 2018-2022 (USD Million)
TABLE 6. Global clinical trials market, 2023 – 2032 (USD Million)
TABLE 7. Global clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 8. Global clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 9. Global clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 10. Global clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 11. Global clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 12. Global clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 13. Global clinical trials market, by region, 2018-2022 (USD Million)
TABLE 14. Global clinical trials market, by region, 2023 – 2032 (USD Million)
TABLE 15. Industry impact forces
TABLE 16. Clinical trials volume analysis, by region, 2018-2022
TABLE 17. Clinical trials volume analysis, by phase development, 2018-2022
TABLE 18. Clinical trials volume analysis, by indication, 2018-2022
TABLE 19. Merger & acquisition landscape
TABLE 20. Phase I market estimates and forecast, 2018-2022 (USD Million)
TABLE 21. Phase I market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 22. Phase II market estimates and forecast, 2018-2022 (USD Million)
TABLE 23. Phase II market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 24. Phase III market estimates and forecast, 2018-2022 (USD Million)
TABLE 25. Phase III market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 26. Phase IV market estimates and forecast, 2018-2022 (USD Million)
TABLE 27. Phase IV market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 28. Interventional study market estimates and forecast, 2018-2022 (USD Million)
TABLE 29. Interventional study market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 30. Observational study market estimates and forecast, 2018-2022 (USD Million)
TABLE 31. Observational study market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 32. Expanded access study market estimates and forecast, 2018-2022 (USD Million)
TABLE 33. Expanded access study market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 34. Autoimmune disease market estimates and forecast, 2018-2022 (USD Million)
TABLE 35. Autoimmune disease market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 36. Oncology market estimates and forecast, 2018-2022 (USD Million)
TABLE 37. Oncology market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 38. Cardiology market estimates and forecast, 2018-2022 (USD Million)
TABLE 39. Cardiology market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 40. Infectious disease market estimates and forecast, 2018-2022 (USD Million)
TABLE 41. Infectious disease market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 42. Dermatology market estimates and forecast, 2018-2022 (USD Million)
TABLE 43. Dermatology market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 44. Ophthalmology market estimates and forecast, 2018-2022 (USD Million)
TABLE 45. Ophthalmology market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 46. Others market estimates and forecast, 2018-2022 (USD Million)
TABLE 47. Others market estimates and forecast, 2023 – 2032 (USD Million)
TABLE 48. North America clinical trials market, by country, 2018-2022 (USD Million)
TABLE 49. North America clinical trials market, by country, 2023 – 2032 (USD Million)
TABLE 50. North America clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 51. North America clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 52. North America clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 53. North America clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 54. North America clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 55. North America clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 56. U.S. clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 57. U.S. clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 58. U.S. clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 59. U.S. clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 60. U.S. clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 61. U.S. clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 62. Canada clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 63. Canada clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 64. Canada clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 65. Canada clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 66. Canada clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 67. Canada clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 68. Europe clinical trials market, by country, 2018-2022 (USD Million)
TABLE 69. Europe clinical trials market, by country, 2023 – 2032 (USD Million)
TABLE 70. Europe clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 71. Europe clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 72. Europe clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 73. Europe clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 74. Europe clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 75. Europe clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 76. Germany clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 77. Germany clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 78. Germany clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 79. Germany clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 80. Germany clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 81. Germany clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 82. UK clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 83. UK clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 84. UK clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 85. UK clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 86. UK clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 87. UK clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 88. France clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 89. France clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 90. France clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 91. France clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 92. France clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 93. France clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 94. Italy clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 95. Italy clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 96. Italy clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 97. Italy clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 98. Italy clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 99. Italy clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 100. Spain clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 101. Spain clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 102. Spain clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 103. Spain clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 104. Spain clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 105. Spain clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 106. Russia clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 107. Russia clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 108. Russia clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 109. Russia clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 110. Russia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 111. Russia clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 112. Poland clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 113. Poland clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 114. Poland clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 115. Poland clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 116. Poland clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 117. Poland clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 118. Netherlands clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 119. Netherlands clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 120. Netherlands clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 121. Netherlands clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 122. Netherlands clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 123. Netherlands clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 124. Switzerland clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 125. Switzerland clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 126. Switzerland clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 127. Switzerland clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 128. Switzerland clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 129. Switzerland clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 130. Rest of Europe clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 131. Rest of Europe clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 132. Rest of Europe clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 133. Rest of Europe clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 134. Rest of Europe clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 135. Rest of Europe clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 136. Asia Pacific clinical trials market, by country, 2018-2022 (USD Million)
TABLE 137. Asia Pacific clinical trials market, by country, 2023 – 2032 (USD Million)
TABLE 138. Asia Pacific clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 139. Asia Pacific clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 140. Asia Pacific clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 141. Asia Pacific clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 142. Asia Pacific clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 143. Asia Pacific clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 144. Japan clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 145. Japan clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 146. Japan clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 147. Japan clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 148. Japan clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 149. Japan clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 150. India clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 151. India clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 152. India clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 153. India clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 154. India clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 155. India clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 156. China clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 157. China clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 158. China clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 159. China clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 160. China clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 161. China clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 162. Australia clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 163. Australia clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 164. Australia clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 165. Australia clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 166. Australia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 167. Australia clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 168. South Korea clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 169. South Korea clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 170. South Korea clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 171. South Korea clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 172. South Korea clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 173. South Korea clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 174. Indonesia clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 175. Indonesia clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 176. Indonesia clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 177. Indonesia clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 178. Indonesia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 179. Indonesia clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 180. Thailand clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 181. Thailand clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 182. Thailand clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 183. Thailand clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 184. Thailand clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 185. Thailand clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 186. Singapore clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 187. Singapore clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 188. Singapore clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 189. Singapore clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 190. Singapore clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 191. Singapore clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 192. Malaysia clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 193. Malaysia clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 194. Malaysia clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 195. Malaysia clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 196. Malaysia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 197. Malaysia clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 198. Philippines clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 199. Philippines clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 200. Philippines clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 201. Philippines clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 202. Philippines clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 203. Philippines clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 204. Rest of Asia Pacific clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 205. Rest of Asia Pacific clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 206. Rest of Asia Pacific clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 207. Rest of Asia Pacific clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 208. Rest of Asia Pacific clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 209. Rest of Asia Pacific clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 210. Latin America clinical trials market, by country, 2018-2022 (USD Million)
TABLE 211. Latin America clinical trials market, by country, 2023 – 2032 (USD Million)
TABLE 212. Latin America clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 213. Latin America clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 214. Latin America clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 215. Latin America clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 216. Latin America clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 217. Latin America clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 218. Brazil clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 219. Brazil clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 220. Brazil clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 221. Brazil clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 222. Brazil clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 223. Brazil clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 224. Mexico clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 225. Mexico clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 226. Mexico clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 227. Mexico clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 228. Mexico clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 229. Mexico clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 230. Argentina clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 231. Argentina clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 232. Argentina clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 233. Argentina clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 234. Argentina clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 235. Argentina clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 236. Colombia clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 237. Colombia clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 238. Colombia clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 239. Colombia clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 240. Colombia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 241. Colombia clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 242. Peru clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 243. Peru clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 244. Peru clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 245. Peru clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 246. Peru clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 247. Peru clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 248. Rest of Latin America clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 249. Rest of Latin America clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 250. Rest of Latin America clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 251. Rest of Latin America clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 252. Rest of Latin America clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 253. MEA clinical trials market, by country, 2018-2022 (USD Million)
TABLE 254. MEA clinical trials market, by country, 2023 – 2032 (USD Million)
TABLE 255. MEA clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 256. MEA clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 257. MEA clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 258. MEA clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 259. MEA clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 260. MEA clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 261. South Africa clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 262. South Africa clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 263. South Africa clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 264. South Africa clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 265. South Africa clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 266. South Africa clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 267. Saudi Arabia clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 268. Saudi Arabia clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 269. Saudi Arabia clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 270. Saudi Arabia clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 271. Saudi Arabia clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 272. Saudi Arabia clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 273. UAE clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 274. UAE clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 275. UAE clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 276. UAE clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 277. UAE clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 278. UAE clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 279. Iraq clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 280. Iraq clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 281. Iraq clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 282. Iraq clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 283. Iraq clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 284. Iraq clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 285. Israel clinical trials market, by phases, 2018-2022 (USD Million)
TABLE 286. Israel clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 287. Israel clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 288. Israel clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 289. Israel clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 290. Israel clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
TABLE 291. Rest of MEA clinical trials market, by phases, 2023 – 2032 (USD Million)
TABLE 292. Rest of MEA clinical trials market, by study design, 2018-2022 (USD Million)
TABLE 293. Rest of MEA clinical trials market, by study design, 2023 – 2032 (USD Million)
TABLE 294. Rest of MEA clinical trials market, by therapeutic area, 2018-2022 (USD Million)
TABLE 295. Rest of MEA clinical trials market, by therapeutic area, 2023 – 2032 (USD Million)
Charts & Figures
FIG. 1 GMI report coverage: Critical research elements
FIG. 2 Industry segmentation
FIG. 3 Bottom-up approach
FIG. 4 Market estimation and forecast methodology
FIG. 5 Market forecasting methodology
FIG. 6 Breakdown of primary participants
FIG. 7 Global clinical trials industry 3600 synopsis, 2018 - 2032 (USD Mn)
FIG. 8 Industry landscape, 2018 - 2032 (USD Million)
FIG. 9 Growth potential analysis, by phases
FIG. 10 Growth potential analysis, by study design
FIG. 11 Growth potential analysis, by therapeutic area
FIG. 12 Porter’s analysis
FIG. 13 PESTEL analysis
FIG. 14 Company matrix analysis, 2022
FIG. 15 Strategic dashboard, 2022
FIG. 16 Competitive analysis of major market players
FIG. 17 Competitive positioning matrix
FIG. 18 Strategic outlook matrix
